169255 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP
NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#2NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#3NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#4NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#5NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#6NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#7METHODS OF EARLY IDENTIFICATION AND EARLY INTERVENTION FOR HIGH-RISK NEONATES WHO OTHERWISE WILL DEVELOP AUTISTIC SOCIAL IMPAIRMENTS LATER IN LIFE
#8METHOD FOR QUANTIFYING NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) OR NICOTINAMIDE MONONUCLEOTIDE (NMN), AND KIT AND FILTER PAPER FOR PERFORMING THE METHOD
#9FLUORESCENT BIOSENSOR FOR ACETYL COENZYME A
#10TREATMENT OF DISORDERS ASSOCIATED WITH LOW BH4 BIOAVAILABILITY
#11NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#12ATP DETECTION
#13SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES
#14A PLATFORM FOR SCREENING NAD+ BINDING PROTEINS IN A CELLULAR CONTEXT
#15TREATMENT OF METABOLIC DISORDERS THROUGH THE TARGETING OF A NOVEL CIRCULATING HORMONE COMPLEX
#16NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same
#17NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#18NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#19NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#20NAD(P)- DEPENDENT RESPONSIVE ENZYMES, ELECTRODES AND SENSORS, AND METHODS FOR MAKING AND USING THE SAME
#21ATP-BASED CELL SORTING AND HYPERPROLIFERATIVE CANCER STEM CELLS
#22EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
#23METHOD
#24Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
#25NAD(P)- Dependent Responsive Enzymes, Electrodes And Sensors, And Methods For Making And Using The Same
#26METHODS FOR THE DESIGN OF NONALLOSTERIC SIRTUIN ACTIVATING COMPOUNDS
#27METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#28ULTRA-HIGH-THROUGHPUT MICROFLUIDIC ENZYME SCREENING PLATFORM FOR ENZYME DEVELOPMENT
#29METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES
#30Methods and compositions for live cell analysis of intracellular ATP
#31Methods for the design of mechanism-based sirtuin activating compounds
#32Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)
#33Device for real-time measurement of bacteria by atp detection
#34NAD(P)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same
#35METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES
#36Methods for treatment of oncological disorders using an epimetabolic shifter (Coenzyme Q10)
#37METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#38Methods for the design of mechanism-based sirtuin activating compounds
#39Sensors, methods and kits for detecting nicotinamide adenine dinucleotides
#40BIOMARKER FOR DETERMINING MITOCHONDRIAL DAMAGE IN FRIEDREICH'S ATAXIA
#41Nicotinamide adenine dinucleotide indicators, methods of preparation and application thereof
#42METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#43PERSONAL GLUCOSE METERS FOR DETECTION AND QUANTIFICATION OF ENZYMES AND METABOLITES BASED ON COENZYME DETECTION
#44SYSTEMS AND METHODS FOR MONITORING BIOLOGICAL FLUIDS
#45Biomarker and Method for Determining an Oxidative Stress Level
#46Compounds useful for FRET and methods related thereto
#47Methods of determining levels of cleaved and/or intact kininogen
#48Luciferase biosensors for cAMP
#49Biomarker for determining mitochondrial damage in friedreich's ataxia
#50Single domain antibodies as inhibitors of PCSK9
#51Method of determining the viability of at least one cell
#52Nicotinamide adenine dinucleotide gene encoding fluorescent probe, preparation method therefor and application thereof
#53Biomarker for abdominal aortic aneurysm
#54Detection methods of NADP(H) using mBFP
#55Compositions and methods for treating colon cancer
#56Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
#57Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
#58Biomarker and Method for Determining an Oxidative Stress Level
#59Method of determining factor XIII with the aid of plasma-based reference material
#60Method for identifying protease inhibitors
#61Sensor
#62Biomarkers and methods for determining disease progression in nonalcoholic steatohepatitis (NASH)
#63SCREENING FOR MODULATORS OF CYP2B15 AND/OR GPD1 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#64METHODS OF ANALYZING SAMPLES FOR BACTERIA USING WHOLE CELL CAPTURE AND ATP ANALYSIS
#65Detection and quantitation of full-length thioredoxin (TRX) and truncated thioredoxin (TRX 80) in complex samples
#66Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
#67METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#68Compositions comprising solanum tuberosum for lowering cytosolic NADH level to mimic calorie restriction
#69Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
#70METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
#71Cobalamin assay
#72METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
#73Methods for measuring ADP
#74Method for identifying protease inhibitors
#75PARP-BASED CYTOCHEMICAL AND HISTOCHEMICAL DETECTION METHODS AND KITS THEREFORE
#76Biomarker and Method for Determining an Oxidative Stress Level
#77Transcobalamin II assay method
#78ASSAY SYSTEM FOR ADENOSINE TRIPHOSPHATE AND CREATINE KINASE
#79Biomarkers for renal disease
#80Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
#81Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
#82Luciferase biosensors for cAMP
#83METHOD OF MEASURING ADENINE NUCLEOTIDE
#84Immunochemical determination method and determination reagent for cytochrome c
#85Method of Judging Fatigue
#86Method of quantifying the G protein-coupled receptor (GPCR)/G protein coupling using a cell membrane array
#87Means and methods for the determination of camp in vitro and in vivo
#88ASSAY METHOD FOR GROUP TRANSFER REACTIONS
#89Assay Method for Group Transfer Reactions
#90Method of testing for ATP load in commercial laundry and for data tracking the results
#91Method of detection of cAMP and cGMP via a fluorophore and dequencher complex
#92Antibody that binds uridine diphosphate
#93Method to Assay Coenzzyme Q10 in Blood Plasma or Blood Serum
#94METHODS AND DEVICES FOR THE DETECTION AND MEASUREMENT OF FREE METALS IN FLUIDS AND METHODS FOR DIAGNOSING METAL-RELATED DISEASES AND FOR DETERMINING PHARMACOLOGIC DOSING REGIMENS
#95Agents that bind to and inhibit human cytochrome P450 2C19
#96Conjugates of mycophenolic acid
#97Test methods for determining the intracellular concentration of cyclic nucleotides
#98Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
#99Cobalamin assay
#100Assay method for group transfer reactions
#101AMPK pathway components
#102Assay for camp based on exclusive binding of camp to the b-binding sites of camp dependent protein kinase (capk)
#103Method of detection and quantification of cGMP by using a cGMP-visualizing probe
#104Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase
#105Method for determining the regulation of xenobiotic removal
#106Natural ligand for orphan G protein coupled receptor GPR86 and methods of use
#107Assay method for group transfer reactions
#108Method of assaying coenzymes a in biological sample
#109Agents that bind to and inhibit human cytochrome P450 2C19
#110Conjugates of mycophenolic acid
#111Modulation of tor